A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer

Ryan J. Brisson, Sara Kochanny, Saba Arshad, Allison Dekker, Jonas A. DeSouza, Vassiliki Saloura, Everett E. Vokes, Tanguy Y. Seiwert

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences